Comorbidity of Paranoid Schizophrenia and Synthetic Cannabinoid Addiction (Advances in Mental Health and Addiction)

This book offers a contemporary perspective on the clinical, dynamic, socio-psychological, and adaptive characteristics of paranoid schizophrenia when it co-occurs with synthetic cannabinoid dependence, based on a large-scale study.It also outlines targeted treatment and rehabilitation programs designed to help patients reintegrate into socially accepted, recovery-focused communities. The study found that the coexistence of these two disorders leads to significant clinical and dynamic changes in both conditions.These include a polymorphism of clinical symptoms during schizophrenia exacerbations, compounded by the addition of synthetic cannabinoid withdrawal syndrome.By the third year, the schizophrenic process often becomes continuously progressive, accompanied by a slow increase in negative psychopathological symptoms and a notable “distortion” of these symptoms. For the first time, six clinical variants of synthetic cannabinoid withdrawal syndrome are described.The book demonstrates